GSE126007 VS-4718 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126007_VS-4718_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126007_VS-4718_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126007_VS-4718_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126007_VS-4718_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

CROCC pseudogene 2

Gene

mitochondrial intermediate peptidase pseudogene 3

Gene

uncharacterized LOC105372832

Gene

SLC12A5 and MMP9 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1118

Gene

small Cajal body-specific RNA 17

Gene

uncharacterized LOC105377557

Gene

stabilizer of axonemal microtubules 3

Gene

uncharacterized LOC105372165

Gene

PRKAG2 antisense RNA 2

  • Gene

    CROCC pseudogene 2


  • Gene

    mitochondrial intermediate peptidase pseudogene 3


  • Gene

    uncharacterized LOC105372832


  • Gene

    SLC12A5 and MMP9 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1118


  • Gene

    small Cajal body-specific RNA 17


  • Gene

    uncharacterized LOC105377557


  • Gene

    stabilizer of axonemal microtubules 3


  • Gene

    uncharacterized LOC105372165


  • Gene

    PRKAG2 antisense RNA 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.